FDA Approved: ERIVEDGE — Original Application (Genentech, Inc.)

View source ↗

Summary

The FDA approved Erivedge (vismodegib) in Genentech's original NDA for the treatment of advanced basal cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Drugs mentioned

• Erivedge (vismodegib)

Snippet

ORIG AP for ERIVEDGE (VISMODEGIB)